Nasdaq: XLO
Xilio Therapeutics insiders
The officers, directors and 10% owners of Xilio Therapeutics, Inc. who hold the most stock, valued at the live XLO price.
$7.51
XLO today −$120K (−1.57%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 3
- Their XLO stock
- $10.1M
- Market value
- $53.1M
- Held by ranked insiders
- 19.1%
Insiders by value of XLO holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Gilead Sciences, Inc. | 10% owner | 650,389 | $4.9M | 9.21% | Corporate |
| 2 | Yekaterina Chudnovsky | 10% owner | 500,000 | $3.8M | 7.08% | 3358th |
| 3 | Atlas Venture Associates Opportunity I, L.P. | 10% owner | 196,794 | $1.5M | 2.79% | Corporate |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Xilio Therapeutics; see each profile for the filing.